--- title: "BrightSpring Health Services - Unit | 10-Q: FY2025 Q2 Revenue: USD 3.148 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/251201135.md" datetime: "2025-08-01T12:48:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/251201135.md) - [en](https://longbridge.com/en/news/251201135.md) - [zh-HK](https://longbridge.com/zh-HK/news/251201135.md) generator: "portal-rs" --- # BrightSpring Health Services - Unit | 10-Q: FY2025 Q2 Revenue: USD 3.148 B Revenue: As of FY2025 Q2, the actual value is USD 3.148 B. EPS: As of FY2025 Q2, the actual value is USD 0.13. EBIT: As of FY2025 Q2, the actual value is USD 9.779 M. ### Pharmacy Solutions Segment - **Revenues**: $2,790.1 million for Q2 2025, up from $2,114.5 million in Q2 2024, an increase of $675.6 million or 32.0%. - **Cost of Goods**: $2,556.4 million for Q2 2025, up from $1,931.8 million in Q2 2024, an increase of $624.6 million or 32.3%. - **Gross Profit**: $233.7 million for Q2 2025, up from $182.7 million in Q2 2024, an increase of $50.9 million or 27.9%. - **Selling, General, and Administrative Expenses**: $136.0 million for Q2 2025, up from $115.5 million in Q2 2024, an increase of $20.6 million or 17.8%. - **Segment EBITDA**: $124.7 million for Q2 2025, up from $94.5 million in Q2 2024, an increase of $30.2 million or 32.0%. ### Provider Services Segment - **Revenues**: $357.6 million for Q2 2025, up from $323.8 million in Q2 2024, an increase of $33.8 million or 10.5%. - **Cost of Services**: $216.4 million for Q2 2025, up from $194.3 million in Q2 2024, an increase of $22.1 million or 11.4%. - **Gross Profit**: $141.2 million for Q2 2025, up from $129.4 million in Q2 2024, an increase of $11.7 million or 9.0%. - **Selling, General, and Administrative Expenses**: $91.9 million for Q2 2025, up from $84.7 million in Q2 2024, an increase of $7.1 million or 8.4%. - **Segment EBITDA**: $56.5 million for Q2 2025, up from $50.7 million in Q2 2024, an increase of $5.8 million or 11.4%. ### Future Outlook and Strategy - **Divestiture of Community Living Business**: The company plans to divest its Community Living business for $835 million, expected to close in late 2025, to focus on senior and specialty populations. - **Strategic Focus**: The divestiture is expected to result in increased strategic focus, operational efficiencies, and greater clinical integration across the Provider Services segment. ### Related Stocks - [BTSGU.US](https://longbridge.com/en/quote/BTSGU.US.md) ## Related News & Research - [Balanced Risk/Reward Keeps Workday at Hold as Brent Thill Raises Price Target from $205 to $225 on Potential Silver Lake Takeout Upside](https://longbridge.com/en/news/296711228.md) - [Danske Bank A S Invests $252.05 Million in Bank of America Corporation $BAC](https://longbridge.com/en/news/296695181.md) - [B. Metzler seel. Sohn & Co. AG Invests $2.26 Million in Axsome Therapeutics, Inc. $AXSM](https://longbridge.com/en/news/296694210.md) - [Benchmark Investment Advisors LLC Purchases Shares of 4,016 Sandisk Corporation $SNDK](https://longbridge.com/en/news/296694361.md) - [SoftBank plans $6.29 billion corporate bond issuance amid AI fundraising boom](https://longbridge.com/en/news/296729829.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**